Come up with a name for your new list and we'll add to it:
Asuragen raised a round of funding on October 23, 2007. Investors include
Merck Global Health Innovation Fund.
Asuragen is a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA. Based in Austin, Texas, the company …